Phillip James Consulting’s Labcorp LH Stock Holding History

Phillip James Consulting’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68K	Hold	6	–	–	﹤0.01%	229
2026 Q1	$1K	Buy	+6	New	+$1.63K	﹤0.01%	307

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Phillip James Consulting's LH Position: Q2 2026 in Review

Phillip James Consulting held its Labcorp (LH) position steady in Q2 2026 at 6 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #229.

Phillip James Consulting first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Phillip James Consulting held 6 shares of Labcorp worth $1.68K as of Q2 2026.
Phillip James Consulting left its Labcorp share count unchanged in Q2 2026.
Labcorp made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #229 holding.
Phillip James Consulting first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.